Legend Biotech Corp ADR (LEGN) — Top EPS Revision Performer
As of 2026-05-05, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 307.25%. Featured in 3 EPS revision reports, most recently on 2026-04-23. Sector: Healthcare.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 307.25%
- EPS growth this year
- 129.86%
- EPS next quarter (est)
- $0.01
- Last price
- $28.51
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-05 | 307.25% | 129.86% | $0.01 | $28.51 |
| 2026-05-04 | 307.25% | 129.86% | $0.01 | $26.50 |
| 2026-05-03 | 307.25% | 129.86% | $0.01 | $23.59 |
| 2026-04-30 | 307.25% | 129.86% | $0.01 | $23.52 |
| 2026-04-29 | 307.25% | 129.86% | $0.01 | $22.77 |
| 2026-04-28 | 307.25% | 129.86% | $0.01 | $23.56 |
| 2026-04-27 | 307.25% | 129.86% | $0.01 | $23.65 |
| 2026-04-26 | 307.25% | 129.86% | $0.01 | $23.90 |
| 2026-04-24 | 307.25% | 129.86% | $0.01 | $23.90 |
| 2026-04-23 | 307.25% | 129.86% | $0.01 | $23.99 |
| 2026-04-22 | 307.25% | 129.86% | $0.01 | $25.93 |
| 2026-04-21 | 307.25% | 129.86% | $0.01 | $25.22 |
| 2026-04-20 | 307.25% | 129.86% | $0.01 | $25.07 |
| 2026-04-19 | 312.32% | 129.49% | $0.01 | $21.17 |
| 2026-04-16 | 312.32% | 129.49% | $0.01 | $21.08 |
| 2026-04-15 | 312.32% | 129.49% | $0.01 | $20.52 |
| 2026-04-14 | 312.32% | 129.49% | $0.01 | $18.69 |
| 2026-04-13 | 311.88% | 129.42% | $0.01 | $17.69 |
| 2026-04-12 | 311.88% | 129.42% | $0.01 | $18.16 |
| 2026-04-10 | 311.88% | 129.42% | $0.01 | $18.09 |
| 2026-04-09 | 311.88% | 129.42% | $0.01 | $18.20 |
| 2026-04-08 | 311.88% | N/A | $0.01 | $18.30 |
| 2026-04-07 | 311.88% | N/A | $0.01 | $17.99 |
| 2026-04-06 | 311.88% | N/A | $0.01 | $17.99 |
| 2026-04-05 | 311.88% | N/A | $0.01 | $19.14 |
| 2026-04-03 | 311.88% | N/A | $0.01 | $17.99 |
| 2026-04-02 | 311.88% | N/A | $0.01 | $17.99 |
| 2026-04-01 | 311.88% | N/A | $0.01 | $17.99 |
| 2026-04-01 | 311.88% | N/A | N/A | $19.05 |
| 2026-04-01 | 311.88% | N/A | N/A | $19.05 |
Reports Featuring LEGN
Recent News
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports